Is Mesco Pharmaceuticals Ltd debt-free?

Yes, Mesco Pharmaceuticals Ltd is debt-free with a debt-to-equity ratio of -1.02.

Home

Mesco Pharmaceuticals Ltd

Mesco Pharmaceuticals Ltd Financials

Mesco Pharmaceuticals Ltd Financial Statement

Mesco Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Dec 2021	Sep 2021	Jun 2021
Revenue	TBA	TBA	TBA
Operating Expense	TBA	TBA	TBA
Net Profit	TBA	TBA	TBA
Net Profit Margin	TBA	TBA	TBA
Earning Per Share	TBA	TBA	TBA
EBIDTA	TBA	TBA	TBA
Effective Tax Rate	TBA	TBA	TBA

Particulars	Dec 2021
Revenue	TBA
Operating Expense	TBA
Net Profit	TBA
Net Profit Margin	TBA
Earning Per Share	TBA
EBIDTA	TBA
Effective Tax Rate	TBA

Mesco Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2021	Mar 2020	Mar 2019
Total Revenue Annual	TBA	TBA	TBA
Operating Expenses Annual	0.00	0.10	0.41
Operating Profit Annual	-0.00	-0.10	-0.41
Interest Annual	0.00	0.00	TBA
Depreciation	TBA	TBA	TBA
Net Profit Annual	-0.00	-0.10	-0.41
Tax Annual	TBA	TBA	TBA

Particulars	Mar 2021
Total Revenue Annual	TBA
Operating Expenses Annual	0.00
Operating Profit Annual	-0.00
Interest Annual	0.00
Depreciation	TBA
Net Profit Annual	-0.00
Tax Annual	TBA

Mesco Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2021	Mar 2020	Mar 2019
Cash Flow at the Beginning	0.04	0.04	0.04
Cash Flow from Operations	TBA	-0.08	-0.39
Cash Flow from Investing	TBA	TBA	TBA
Cash Flow from Financing	-0.03	0.08	0.39
Cash Flow at the End	TBA	0.04	0.04

Particulars	Mar 2021
Cash Flow at the Beginning	0.04
Cash Flow from Operations	TBA
Cash Flow from Investing	TBA
Cash Flow from Financing	-0.03
Cash Flow at the End	TBA

Mesco Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2021	Mar 2020	Mar 2019
PBDIT Margin (%)	TBA	TBA	TBA
PBIT Margin (%)	TBA	TBA	TBA
PBT Margin (%)	TBA	TBA	TBA
Net PROFIT Margin (%)	TBA	TBA	TBA
Return On Networth / Equity (%)	TBA	TBA	TBA
Return On Networth /Employed (%)	TBA	TBA	TBA
Return On Assets (%)	TBA	TBA	TBA
Total Debt / Equity (X)	TBA	TBA	TBA
Asset Turnover Ratio (%)	TBA	TBA	TBA

Particulars	Mar 2021
PBDIT Margin (%)	TBA
PBIT Margin (%)	TBA
PBT Margin (%)	TBA
Net PROFIT Margin (%)	TBA
Return On Networth / Equity (%)	TBA
Return On Networth /Employed (%)	TBA
Return On Assets (%)	TBA
Total Debt / Equity (X)	TBA
Asset Turnover Ratio (%)	TBA

Mesco Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2021	Mar 2020	Mar 2019
Fixed Assets Annual	0.18	0.18	0.18
Total Current Assets Annual	0.00	0.04	0.04
Non Current Assets Annual	0.18	0.18	0.21
Total Shareholders Funds Annual	-11.02	-11.01	-10.91
Total Assets Annual	0.18	0.22	0.25

Particulars	Mar 2021
Fixed Assets Annual	0.18
Total Current Assets Annual	0.00
Non Current Assets Annual	0.18
Total Shareholders Funds Annual	-11.02
Total Assets Annual	0.18

Mesco Pharmaceuticals Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Mesco Pharmaceuticals Ltd Financials

As of Oct 29, 2025, Mesco Pharmaceuticals Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Mesco Pharmaceuticals Ltd is with a debt-to-equity ratio of -1.02.

In FY 2024 , Mesco Pharmaceuticals Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.

Mesco Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and NaN% annually, respectively..

Mesco Pharmaceuticals Ltd's current PE ratio is 0.00.

Mesco Pharmaceuticals Ltd's ROCE averaged -77.7% from the FY ending March 2019 to 2021, with a median of -48.0%. It peaked at -2.4% in March 2021, reflecting strong capital efficiency over the period..

Mesco Pharmaceuticals Ltd's latest EBIT is Rs. 0 Cr, surpassing the average EBIT of Rs. -0.17 Cr over the 5 years..